These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 15732917)
1. High-throughput solution-based medicinal library screening against human serum albumin. Flarakos J; Morand KL; Vouros P Anal Chem; 2005 Mar; 77(5):1345-53. PubMed ID: 15732917 [TBL] [Abstract][Full Text] [Related]
2. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures. Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178 [TBL] [Abstract][Full Text] [Related]
3. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins. Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758 [TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric techniques for label-free high-throughput screening in drug discovery. Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631 [TBL] [Abstract][Full Text] [Related]
5. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins. Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813 [TBL] [Abstract][Full Text] [Related]
6. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. Rich RL; Day YS; Morton TA; Myszka DG Anal Biochem; 2001 Sep; 296(2):197-207. PubMed ID: 11554715 [TBL] [Abstract][Full Text] [Related]
7. Affinity ligand selection from a library of small molecules: assay development, screening, and application. Saraswat LD; Zhang H; Hardy LW; Jones SS; Bhikhabhai R; Brink C; Bergenstråhle A; Haglund R; Gallion SL Biotechnol Prog; 2005; 21(1):300-8. PubMed ID: 15903269 [TBL] [Abstract][Full Text] [Related]
8. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry. Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042 [TBL] [Abstract][Full Text] [Related]
9. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results. Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870 [TBL] [Abstract][Full Text] [Related]
10. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry. Cheng Y; Ho E; Subramanyam B; Tseng JL J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095 [TBL] [Abstract][Full Text] [Related]
11. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry. Wabnitz PA; Loo JA Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252 [TBL] [Abstract][Full Text] [Related]
12. Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry. Gu C; Nikolic D; Lai J; Xu X; van Breemen RB Comb Chem High Throughput Screen; 1999 Dec; 2(6):353-9. PubMed ID: 10644860 [TBL] [Abstract][Full Text] [Related]
13. Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions. Ascoli GA; Bertucci C; Salvadori P Biomed Chromatogr; 1998; 12(5):248-54. PubMed ID: 9787894 [TBL] [Abstract][Full Text] [Related]
14. Determination of drug-plasma protein binding using human serum albumin chromatographic column and multiple linear regression model. Beaudry F; Coutu M; Brown NK Biomed Chromatogr; 1999 Oct; 13(6):401-6. PubMed ID: 10477897 [TBL] [Abstract][Full Text] [Related]
15. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction. Benkestock K; Edlund PO; Roeraade J Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474 [TBL] [Abstract][Full Text] [Related]
16. Screening major binding sites on human serum albumin by affinity capillary electrophoresis. Kim HS; Austin J; Hage DS Methods Mol Biol; 2004; 276():169-87. PubMed ID: 15163858 [TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry and combinatorial chemistry: a short outline. Triolo A; Altamura M; Cardinali F; Sisto A; Maggi CA J Mass Spectrom; 2001 Dec; 36(12):1249-59. PubMed ID: 11754116 [TBL] [Abstract][Full Text] [Related]
18. [Fast liquid chromatographic method to determine compounds binding to human serum albumin]. Valkó K Acta Pharm Hung; 2003; 73(1):13-22. PubMed ID: 12891895 [TBL] [Abstract][Full Text] [Related]
19. Method for quantitative protein-ligand affinity measurements in compound mixtures. Annis DA; Shipps GW; Deng Y; Popovici-Müller J; Siddiqui MA; Curran PJ; Gowen M; Windsor WT Anal Chem; 2007 Jun; 79(12):4538-42. PubMed ID: 17500537 [TBL] [Abstract][Full Text] [Related]
20. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies. Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]